Page last updated: 2024-08-25

chitosan and rifamycins

chitosan has been researched along with rifamycins in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, J; Newton, AMJ	1

Other Studies

1 other study(ies) available for chitosan and rifamycins

Article	Year
Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD). Recent patents on inflammation & allergy drug discovery, 2017, Volume: 11, Issue:1 Topics: Animals; Chitosan; Drug Delivery Systems; Drug Design; Drug Liberation; Drug Stability; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Patents as Topic; Rats; Rifamycins; Rifaximin; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction	2017

Article

Year

Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).

Recent patents on inflammation & allergy drug discovery, 2017, Volume: 11, Issue:1

Topics: Animals; Chitosan; Drug Delivery Systems; Drug Design; Drug Liberation; Drug Stability; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Patents as Topic; Rats; Rifamycins; Rifaximin; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2017